EMHTF - Emerald Health Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
2.7744
-0.0656 (-2.31%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close2.8400
Open2.8500
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range2.7500 - 2.9000
52 Week Range1.4800 - 4.5000
Volume445,225
Avg. Volume559,159
Market Cap397.796M
Beta (3Y Monthly)3.06
PE Ratio (TTM)N/A
EPS (TTM)-0.1290
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • CNW Group4 days ago

    Governments Change Tune on Cannabis With Softened Regulations

    NEW YORK, April 15, 2019 /CNW/ -- As the cannabis industry has expanded, the methods of ingestion have also changed. The medical benefits of cannabis have allowed the industry to grow rapidly over the past several years with Canada even legalizing cannabis entirely for both medical and recreational use just last year. Then, one month later, U.S. states Michigan, Missouri, and Utah legalized cannabis on some form, bringing the number of states with cannabis legislation to a total of 33, as well as the District of Columbia.

  • ACCESSWIRE8 days ago

    Cannabis Stocks to Watch

    HENDERSON NV / ACCESSWIRE / April 11, 2019 / With the market off to its best first quarter over the past 2 decades and the cannabis industry being one of the hottest in the market, now is an ideal time ...

  • GlobeNewswire10 days ago

    Emerald Health Therapeutics to Present at Investment Conferences in April

    OTCQX: EMHTF), a licensed producer of cannabis products for medical and recreational purposes, announced today that executives of the company will participate in multiple upcoming investment conferences.

  • GlobeNewswire11 days ago

    Emerald Health Therapeutics Receives Standard Processing License for Verdélite Facility in Quebec

    OTCQX: EMHTF) today announced that its Québec facility, Verdélite, has received its Standard Processing License from Health Canada. This license means that, in addition to Verdélite’s right to cultivate and sell cannabis flowers, it can now extract, manufacture, synthesize, test and sell next-generation cannabis products and will position Verdélite to launch these products in conjunction with the expected legalization of a broader spectrum of cannabis products in Canada in October 2019.

  • How Medical Marijuana Stocks Performed on April 4
    Market Realist14 days ago

    How Medical Marijuana Stocks Performed on April 4

    How Medical Marijuana Stocks Performed on April 4(Continued from Prior Part)Medical marijuana stocks The cannabis sector saw some weakness on April 4. The ETFMG Alternate Harvest ETF (MJ) saw a negative price action of 0.11%. Charlotte’s Web

  • CNW Group15 days ago

    Cannabis Market Brief: U.S. Currently 2nd to China In CBD-Hemp Revenues

    PALM BEACH, Florida, April 4, 2019 /CNW/ -- A recent report from an independent, technology-driven analytics company specializing in the cannabis industry stated that: "… the global hemp industry reached $3.7 billion USD in retail sales in 2018, with an annual growth rate of 15% driven by continued strength in Chinese textiles, European industrials, Canadian foods, and the U.S. hemp-derived CBD market. China led all countries with nearly $1.2 billion USD in hemp sales in 2018, followed by the United States ($1.0 billion), Europe ($980 million) and South and Central America ($220 million). The U.S. market is positioned to grow under the 2018 Farm Bill, with an estimated $2.6 billion projected in sales by 2022, with $1.3 billion in sales estimated for hemp-derived CBD products by 2022. "As regulatory barriers diminish in the months and years ahead, businesses will continue to expand the ways in which hemp is utilized, especially across medicinal and industrial applications," said (the author).

  • GlobeNewswire16 days ago

    Emerald Health Therapeutics Signs Letter of Intent to Supply Cannabis to Québec Market

    OTCQX: EMHTF) has signed a letter of intent to supply cannabis to the Société Québécoise du Cannabis (SQDC), Quebec's sole legal distributor of recreational cannabis. Under the agreement, Emerald will supply cannabis to the SQDC from its Québec-based Saint-Eustache facility, Verdélite, as well as from its 50%-owned joint venture, Pure Sunfarms, in Delta, BC. Emerald will fulfill its first supply order in Q2 2019. “Québec’s population of 8.4 million is a sizable market and we are pleased to be able to offer locally-grown, quality cannabis products to the adult-use consumers throughout the province,” said Dr. Avtar Dhillon, President and Executive Chairman of Emerald.

  • CNW Group17 days ago

    Regions Continue to Shift Towards CBD Legalization With Growing List of Medical Applications

    NEW YORK, April 2, 2019 /CNW/ -- The proliferation of cannabidiol, or CBD-based products, has exploded after U.S. President Donald Trump signed the Farm Bill in December 2018. Now, CBD products are appearing at supermarkets, health and wellness stores, smoke shops, coffee shops, and farmer's markets around the country. Due to the rapid emergence of the industry, CBD products have expanded outwards from traditional oils and tinctures to shampoos, bath bombs, pet treats, and gummy bears.

  • GlobeNewswire18 days ago

    Emerald’s Pure Sunfarms Joint Venture Acquires Second 1.1 Million Square Foot Greenhouse, Doubling Potential Production Capacity to 150,000 Kilograms

    OTCQX: EMHTF) today announced that its 50%-owned joint venture, Pure Sunfarms, has exercised its option to acquire from Village Farms International, Inc. (“Village Farms”) a second 1.1 million square foot (25 acre) greenhouse (“Delta 2”) adjacent to Pure Sunfarms’ existing 1.1 million square foot cannabis operation (“Delta 3”) in Delta, BC. Pure Sunfarms expects to reach its annualized full production run-rate of approximately 75,000 kilograms by mid-year at Delta 3 and expects to double its overall production on completion of the conversion of Delta 2. Emerald has also entered into an agreement with Pure Sunfarms to purchase 25% of its aggregate cannabis production from Delta 3 and Delta 2 in 2020, 2021 and 2022.

  • GlobeNewswire21 days ago

    Emerald Health Therapeutics Delivers to Yukon and Adds Supply Agreements with Alberta and Saskatchewan

    OTCQX: EMHTF) has fulfilled its first purchase order of cannabis from Yukon Liquor Corporation, signed a sales agreement with Alberta Gaming, Liquor and Cannabis (AGLC), and become officially registered by the Saskatchewan Liquor and Gaming Authority (SLGA) to supply cannabis to the Saskatchewan market. “We are pleased to provide our Emerald-branded cannabis products to the adult-use markets in Alberta, Saskatchewan and the Yukon,” said Dr. Avtar Dhillon, President and Executive Chairman of Emerald.

  • GlobeNewswire22 days ago

    Emerald Health Therapeutics Announces At-the-Market Equity Program

    OTCQX:EMHTF) today announced that it has established an at-the-market equity program (“ATM Program”) that allows the Company to issue common shares from treasury (“Common Shares”) having an aggregate gross sales price of up to $39 million to the public from time to time, at the Company’s discretion, at the prevailing market price when issued on the TSX Venture Exchange (“TSXV”) or on any other marketplace for the Common Shares in Canada. The ATM Program is effective until the earlier of April 13, 2021 or completion of the sale of the maximum amount of shares thereunder and will be activated from time to time at the Company’s discretion if and when required based on the Company’s working capital requirements and capital expenditures and relative cost of other funding options.

  • CNW Group24 days ago

    Widespread Cannabis Reform Continues With Growing Patient and Elderly Use

    NEW YORK, March 26, 2019 /CNW/ -- Following Canada's legalization of cannabis and the U.S.'s ongoing efforts, cannabis-based companies have seen their revenue grow substantially over the past few years. In the past quarter alone, major events had occurred within the North American region, bolstering the cannabis industry further. Last year in October, Canada legalized cannabis entirely for both medical and recreational use.

  • CNW Group29 days ago

    U.S. And Canadian Dispensaries Now Looking to Locate in Local Malls

    PALM BEACH, Florida, March 21, 2019 /CNW/ -- An industry publication recently said that, in both Canada and the U.S.: "The future is very bright for property owners in North America as cannabis companies are on the hunt for cannabis retail locations." The article said that: "Cannabis retailers aren't very widespread in Canada as most provincial governments are slow to roll out the licenses needed to open the stores. In other developments in the industry, a recent headline projecting what will happen in the 2019 cannabis markets, used a tongue-in-cheek cliché: "High Times Ahead: Continued Dramatic Growth Expected For The Legal Cannabis Industry In 2019." High times are indeed projected.

  • ACCESSWIRElast month

    New Cannabis Stocks Gunning for the Top-THC Therapeutics Inc.

    HENDERSON, NV / ACCESSWIRE / March 20, 2019 / With cannabis in the news and investors becoming more and more hungry for the next big winner in the industry, we decided to highlight a couple that could ...

  • GlobeNewswirelast month

    Emerald Health Therapeutics Applauds Government of Canada for Proposing Amendment to Cannabis Excise Tax in Federal Budget

    OTCQX: EMHTF) applauds the Government of Canada for proposing to amend the excise tax calculation for cannabis in the federal budget announced yesterday. The implementation of the proposed revision announced in the federal budget would result in the calculation of the excise duty of ingestible cannabis and hemp products being based on the quantity of THC in the products, as opposed to the current tax set in relation to the product volume.

  • ACCESSWIRElast month

    These Four Marijuana Stocks are Heating Up on Tuesday

    CORAL GABLES, FL / ACCESSWIRE / March 19, 2019 / One of the longest-running ways to reach the top of the marijuana stock market has been for companies to invest in growing cannabis. Taking that into consideration, there are companies that are seeing impressive gains as a result of their focus being the improvement of products for consumers in the cannabis market. Leafbuyer Technologies Inc (OTC:LBUY), Auxly Cannabis Group Inc (OTCQX:CBWTF), Emerald Health Therapeutics Inc (EMHTF), and HEXO Corp (NYSE American: HEXO, TSX: HEXO) represent 4 marijuana stocks looking strong on Tuesday.

  • CNW Grouplast month

    States Attract New Wave of Tourism With Legalized Cannabis

    NEW YORK, March 18, 2019 /CNW/ --Last year, Canada became the second country ever to legalize cannabis entirely, joining Uruguay as the world pacesetters. Now, visitors across the world are flocking to the nation to try legal cannabis. Currently, the U.S. has only 10 states and the District of Columbia that have legalized cannabis entirely and states such as California, Colorado, and Nevada are the biggest market drivers.

  • GlobeNewswirelast month

    Emerald Health Therapeutics Appoints Vice President, Communications and Stakeholder Relations

    OTCQX:EMHTF) announced today that Allan Rewak has been appointed Vice President, Communications and Stakeholder Relations, effective April 15, 2019. Prior to joining Emerald, Mr. Rewak was the Executive Director at the Cannabis Council of Canada (C3), Canada’s national industry association for cannabis, cultivators and processors. For his work, the Financial Post named him “One of the 20 Power Players Setting Down Roots in the Cannabis Industry”.

  • CNW Grouplast month

    CBD Infused Beverages Go Mainstream Along With Big Revenue Projections

    PALM BEACH, Florida , March 14, 2019 /CNW/ -- The big-box stores and the multi-national beverage companies have been sitting on the sidelines while the CBD/THC infused products markets have been virtually ...

  • GlobeNewswirelast month

    Emerald Health Therapeutics Continues to Grow Sales with First Cannabis Shipment to Ontario Cannabis Retail Corporation

    OTCQX:EMHTF) has fulfilled its first purchase order of cannabis from Ontario Cannabis Retail Corporation, operating as the Ontario Cannabis Store (“OCS”). “As we scale up production in our wholly-owned, premium indoor growing facility, Verdélite, and our large-scale, state-of-the-art joint venture greenhouse operation, Pure Sunfarms, we are consistently meeting our supply commitments of Emerald-branded adult-use cannabis in British Columbia and Newfoundland Labrador, and we are now prepared to provide the same service to the Ontario Cannabis Retail Corporation and other provinces,” said Dr. Avtar Dhillon, President and Executive Chairman of Emerald. Currently, Emerald’s cannabis supply is provided primarily through its 88,000 sq. ft. Verdélite indoor facility in Saint Eustache, Quebec, and through Pure Sunfarms, its 50%-owned 1.1 million sq. ft. greenhouse facility in Delta, British Columbia.

  • CNW Grouplast month

    Why Cannabis Cultivators are now Seeking Larger Scale Options

    PALM BEACH, Florida, March 12, 2019 /CNW/ -- Cannabis growers are increasing revenues in a number of ways. Forbes recently looked at this key sector saying: "The current "green rush" has brought with it an intense focus on large-scale cannabis cultivation. In the United States, cultivation licenses are often viewed as the most valuable in the highly competitive application processes that most states use to determine who is allowed to cultivate and dispense in their states."   Active companies in the cannabis industry includes:  CROP INFRASTRUCTURE CORP. (CSE:CROP) (OTC:CRXPF - News), The Supreme Cannabis Company, Inc. (OTC:SPRWF - News) (TSX:FIRE), Terra Tech Corp. (OTC:TRTC - News), The Green Organic Dutchman Holdings Ltd. (OTC:TGODF - News) (TSX:TGOD), Emerald Health Therapeutics, Inc. (OTC:EMHTF - News) (TSX-V:EMH.V - News).

  • GlobeNewswirelast month

    Cannabis Stocks That Could See Significant Growth in Retail

    Cannabis sales have been soaring since legalization in Canada but there's a lot more to come as the industry continues to change. Here are some of the hottest cannabis stocks right now that are positioning themselves to take advantage of the fast-growing retail market. Westleaf has been making a name for itself in the industry as it looks to become a dominant force in the retail market.

  • ACCESSWIRElast month

    Four Marijuana Stocks Gaining Speed On Monday

    CORAL GABLES, FL / ACCESSWIRE / March 11, 2019 / It's quite astounding that the marijuana stock market continues to receive so much attention despite the nascent nature of the cannabis industry. Having said that, the cannabis industry has seen a boom in excitement this past year as a result of lawmakers pushing for legislation in support of marijuana legalization. Global Consortium Inc (OTC:GCGX), Aphria Inc (APHA), Emerald Health Therapeutics Inc (EMHTF), and Innovative Industrial Properties Inc (IIPR) are 4 marijuana stocks heating up on Monday.

  • GlobeNewswirelast month

    Emerald Health Therapeutics Sees Pure Sunfarms Licensed for 1.03 Million Square Feet of Cannabis Cultivation; Full Planting Targeted for End of April

    OTCQX:EMHTF) today announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms Corp. (“Pure Sunfarms”), received from Health Canada its seventh amendment to its cultivation license for its 1.1 million square foot greenhouse in Delta, BC. The additional approximately 206,000 square feet of growing area in the fourth and final quadrant of the greenhouse brings Pure Sunfarms’ total licensed cannabis production area to approximately 1.03 million sq. ft. in 16 grow rooms. “Pure Sunfarms is now licensed across all its growing areas and we congratulate their team for this significant accomplishment,” said Dr. Avtar Dhillon, President and Executive Chairman of Emerald. “With Emerald’s 50% stake in one of the largest fully operational cannabis production facilities in the world, we expect to realize significant economic value from Pure Sunfarms.

  • CNW Grouplast month

    Change of Global Legislature Could Prompt Greater Cannabis Market Expansion

    NEW YORK, March 7, 2019 /CNW/ -- With the recent boom in the cannabis industry, the plant is being exported around the globe to various countries for medicinal uses. Various researches that have been conducted have linked cannabis to effectively treating conditions such as dementia, behavioral disorder, and chronic pain. Tikun Olam, Israel's veteran medical cannabis company, is among the multitude of organizations undergoing cannabis research.